December 2021
Author Information
Doi T (1), Kuboki Y(1), Naito Y (1), Ishida M (2), Tanaka T (3), Takeuchi Y (4)
(1) Dept of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan. (2) Nippon Boehringer Ingelheim Co., Ltd, Kobe, Japan. (3) EPS Corporation, Tokyo, Japan. (4) Nippon Boehringer Ingelheim Co, Ltd, Tokyo, Japan.
Publication
Cancer Sci
© Desmoid Tumor Research Foundation (DTRF) | c/o CliftonLarsonAllen LLP, 50 Tice Blvd, Suite 175, Woodcliff Lake, NJ 07677